ActoGeniX N.V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ActoGeniX N.V..The latest application filed is for "method to improve lactococcus preservation".

Company Profile

0.10.22

ActoGeniX N.V. - Zwijnaarde BE
ACTOGENIX NV - Zwijnaarde BE
Actogenix N.V. - Zwijnaade BE
Actogenix NV - BE BE
ActoGeniX N V - Zwijnaarde BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method To Improve Lactococcus Preservation App 20160076044 - Remaut; Erik ; et al.	2016-03-17
Method to improve Lactococcus preservation Grant 9,200,249 - Remaut , et al. December 1, 2	2015-12-01
Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis Grant 9,017,662 - Rottiers , et al. April 28, 2	2015-04-28
Induction Of Mucosal Tolerance To Antigens App 20140322230 - Rottiers; Pieter ; et al.	2014-10-30
Induction Of Mucosal Tolerance To Antigens App 20140322266 - Rottiers; Pieter ; et al.	2014-10-30
Modified Gram Positive Bacteria And Uses Thereof App 20140234371 - Steidler; Lothar ; et al.	2014-08-21
Modified Gram Positive Bacteria And Uses Thereof App 20140227229 - Steidler; Lothar ; et al.	2014-08-14
Lactococcus promoters and uses thereof Grant 8,759,088 - Steidler , et al. June 24, 2	2014-06-24
Induction of mucosal tolerance to antigens Grant 8,748,126 - Rottiers , et al. June 10, 2	2014-06-10
Polycistronic Expression System For Bacteria App 20140105863 - Vanden-Broucke; Klaas ; et al.	2014-04-17
Treatment Of Immune Disease By Mucosal Delivery Of Antigens Using Genetically Modified Lactobacillus App 20130330374 - Rottiers; Pieter ; et al.	2013-12-12
Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus Grant 8,524,246 - Rottiers , et al. September 3, 2	2013-09-03
Compositions And Methods For Treating Inflammatory Conditions App 20130164380 - Durum; Scott K. ; et al.	2013-06-27
Treatment Of Immune Disease By Mucosal Delivery Of Antigens Using Genetically Modified Lactobacillus App 20130095129 - Rottiers; Pieter ; et al.	2013-04-18
Method of inducing immune tolerance to type I diabetes Grant 8,398,995 - Rottiers , et al. March 19, 2	2013-03-19
Lactobacillus And Streptococcus Promoters And Uses Thereof App 20120183503 - Steidler; Lothar ; et al.	2012-07-19
Cryoprotectants For Freeze Drying Of Lactic Acid Bacteria App 20120039853 - Corveleyn; Sam ; et al.	2012-02-16
Delivery Of Binding Molecules To Induce Immunomodulation App 20100303777 - De Creus; An ; et al.	2010-12-02
Self-containing Lactococcus strain Grant 7,780,961 - Steidler August 24, 2	2010-08-24
Method Of Inducing Immune Tolerance To Type I Diabetes App 20100172920 - ROTTIERS; PIETER ; et al.	2010-07-08
Lactococcus Promoters And Uses Thereof App 20100080774 - Steidler; Lothar ; et al.	2010-04-01
Methods and means to promote gut absorption Grant 7,601,799 - Steidler October 13, 2	2009-10-13
Delivery of trefoil peptides Grant 7,592,013 - Hans , et al. September 22, 2	2009-09-22
Induction Of Mucosal Tolerance To Antigens App 20090148389 - Rottiers; Pieter ; et al.	2009-06-11
Microbial Intestinal Delivery Of Obesity Related Peptides App 20090074734 - Rottiers; Pieter	2009-03-19
Anti-Tnf Alpha Producing Lactic Acid Bacteria for the Treatment of Chronic Enterocolitis App 20080274084 - Rottiers; Pieter ; et al.	2008-11-06
Use of Recombinant Yeast Strain Producing an Anti-Inflammatory Compound to Treat Colitis App 20080254014 - Rottiers; Pieter ; et al.	2008-10-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.